Etilevodopa
Systematic (IUPAC) name | |
---|---|
ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate | |
Identifiers | |
CAS Number | 37178-37-3 |
ATC code | N04BA06 (WHO) (combination with decarboxylase inhibitor) |
PubChem | CID 170345 |
ChemSpider | 148944 |
UNII | 895X917GYE |
KEGG | D04097 |
Chemical data | |
Formula | C11H15NO4 |
Molar mass | 225.241 g/mol |
| |
| |
(verify) |
Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.
See also
References
- ↑ Djaldetti Ruth, Giladi Nir, Hassin-Baer Sharon, Shabtai Hertzel, Melamed Eldad (November–December 2003). "Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study". Clinical Neuropharmacology 26 (6): 322–326. doi:10.1097/00002826-200311000-00012.
|
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.